Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Presse Medicale (Paris, France : 1983)
|
March 12, 2019
Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)
Alexandre Pariente, Jean-Pierre Arpurt, André-Jean Rémy, et al.
Annals of Hepatology
|
May 23, 2019
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals
Alexandre Pariente, Jean-Pierre Arpurt, Andre-Jean Remy, et al.
Journal of Hepatology
|
September 14, 2016
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Stanislas Pol, Marc Bourliere, Sandy Lucier, et al.
BMC Infectious Diseases
|
January 28, 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
Georges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, et al.
Lancet (London, England)
|
February 16, 2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Fabrice Carrat, Hélène Fontaine, Céline Dorival, et al.
European Journal of Gastroenterology & Hepatology
|
May 5, 2018
Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study
Manon Allaire, Jean-François D Cadranel, Christophe Bureau, et al.
JHEP Reports : Innovation in Hepatology
|
July 24, 2024
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort
Victor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, et al.
Clinics and Research in Hepatology and Gastroenterology
|
April 30, 2021
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study
Laurent Lam, Hélène Fontaine, Marc Bourliere, et al.
Journal of Hepatology
|
May 15, 2013
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890
Christophe Hézode, Hélène Fontaine, Céline Dorival, et al.
Gastroenterology
|
April 8, 2014
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis
Christophe Hézode, Helene Fontaine, Celine Dorival, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Presse Medicale (Paris, France : 1983)
|
March 12, 2019
Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)
Alexandre Pariente, Jean-Pierre Arpurt, André-Jean Rémy, et al.
Annals of Hepatology
|
May 23, 2019
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals
Alexandre Pariente, Jean-Pierre Arpurt, Andre-Jean Remy, et al.
Journal of Hepatology
|
September 14, 2016
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Stanislas Pol, Marc Bourliere, Sandy Lucier, et al.
BMC Infectious Diseases
|
January 28, 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
Georges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, et al.
Lancet (London, England)
|
February 16, 2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Fabrice Carrat, Hélène Fontaine, Céline Dorival, et al.
European Journal of Gastroenterology & Hepatology
|
May 5, 2018
Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study
Manon Allaire, Jean-François D Cadranel, Christophe Bureau, et al.
JHEP Reports : Innovation in Hepatology
|
July 24, 2024
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort
Victor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, et al.
Clinics and Research in Hepatology and Gastroenterology
|
April 30, 2021
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study
Laurent Lam, Hélène Fontaine, Marc Bourliere, et al.
Journal of Hepatology
|
May 15, 2013
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890
Christophe Hézode, Hélène Fontaine, Céline Dorival, et al.
Gastroenterology
|
April 8, 2014
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis
Christophe Hézode, Helene Fontaine, Celine Dorival, et al.
Page
of 5